What is the recommended treatment for severe symptomatic hyponatremia using 3% (three percent) saline?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

For severe symptomatic hyponatremia, the recommended treatment is 3% hypertonic saline, which may improve hyponatremia at the cost of worsening fluid overload, and is best reserved for those with severely symptomatic acute hyponatremia, especially if a transplant is imminent 1.

Key Considerations

  • The goal is to raise serum sodium by up to 5 mmol/L in the first hour, with a limit of 8–10 mmol/L every 24 hours thereafter, until the serum sodium concentration reaches 130 mmol/L 1.
  • Administration of 3% saline should be done with caution, as it may worsen fluid overload, and patients should be closely monitored in an ICU setting with frequent neurological checks.
  • The underlying cause of hyponatremia should be identified and treated simultaneously.

Treatment Approach

  • Initial treatment with 3% hypertonic saline can be administered as an IV bolus, with the goal of raising serum sodium levels to relieve acute symptoms.
  • After initial bolus therapy, a slower continuous infusion of 3% saline can be used, with frequent monitoring of serum sodium levels.
  • Patients with severe symptomatic hyponatremia require close monitoring and individualized treatment to balance the risk of too-rapid correction and prevent osmotic demyelination syndrome.

Important Considerations

  • The use of 3% saline is generally recommended for patients with severely symptomatic acute hyponatremia, especially if a transplant is imminent 1.
  • Other treatments, such as fluid restriction and diuretics, may be considered in patients with cirrhosis and ascites, but the use of 3% saline is specifically recommended for severe symptomatic hyponatremia 1.

From the Research

Treatment of Severe Symptomatic Hyponatremia

  • The recommended treatment for severe symptomatic hyponatremia is bolus hypertonic saline to reverse hyponatremic encephalopathy by increasing the serum sodium level by 4 mEq/L to 6 mEq/L within 1 to 2 hours but by no more than 10 mEq/L within the first 24 hours 2.
  • Hypertonic saline (3%) infusion is usually used to obtain rapid correction of symptomatic hyponatremia 3, 4, 5.
  • The European guidelines recommend bolus-wise administration of 150 mL of 3% hypertonic saline for the treatment of symptomatic hyponatremia 5.
  • Treatment target is defined as an increase in serum sodium by 5-10 mEq/L within the first 24 hours and a maximum of 8 mEq/L during subsequent 24 hours 5.
  • Overly rapid correction of hyponatremia may cause osmotic demyelination, a rare but severe neurological condition, which can result in parkinsonism, quadriparesis, or even death 2, 3, 4.

Administration and Monitoring

  • Frequent monitoring of the serum sodium concentration and urine output are mandatory during treatment with hypertonic saline 4, 5.
  • Administration of desmopressin to terminate an unwanted water diuresis is an effective strategy to avoid or reverse overcorrection 4.
  • Reducing bolus-volume and reevaluation before repeating bolus infusion might prevent overcorrection 5.
  • Diuresis should be monitored to avoid misinterpreting symptoms caused by hypovolemia as severely symptomatic hyponatremia 5.

Risks and Complications

  • Overcorrection of hyponatremia risks iatrogenic brain damage 2, 3, 4.
  • The risks of brain myelinolysis can be largely reduced by limiting the correction level to < or = 15 mEq/1/24 h 3.
  • Demyelinization is also observed in hypernatremia but it follows a greater (50%) increase in serum sodium than from hyponatremic baseline 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.